Neonatal abstinence syndrome: Historical perspective, current focus, future directions (Q38978809)

8 September 2017

Neonatal abstinence syndrome: Historical perspective, current focus, future directions (English)

1 reference

neonatal abstinence syndrome

8 September 2017

1 reference

1

Hendrée E Jones

1 reference

8 September 2017

Andrea Fielder

2

1 reference

PubMed ID

26232620

8 September 2017

language of work or name

English

0 references

publication date

29 July 2015

1 reference

8 September 2017

1 reference

8 September 2017

80

1 reference

8 September 2017

12-17

1 reference

An evaluation of rooming-in among substance-exposed newborns in British Columbia

8 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

Pregnancy in narcotics addicts treated by medical withdrawal. The methadone detoxification program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

Diluted tincture of opium (DTO) and phenobarbital versus DTO alone for neonatal opiate withdrawal in term infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

Newborn evaluations of toxicity and withdrawal related to prenatal cocaine exposure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

Comparison of methadone and slow-release morphine maintenance in pregnant addicts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

Opioid and benzodiazepine withdrawal symptoms in paediatric intensive care patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

The Withdrawal Assessment Tool-1 (WAT-1): an assessment instrument for monitoring opioid and benzodiazepine withdrawal symptoms in pediatric patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

Time to initiation of treatment for neonatal abstinence syndrome in neonates exposed in utero to buprenorphine or methadone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

The effects of maternal narcotic addiction on the newborn

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

Ineffective morphine treatment regimen for the control of Neonatal Abstinence Syndrome in buprenorphine- and methadone-exposed infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

The Neonatal Narcotic Withdrawal Index: A Device for the Improvement of Care in the Abstinence Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

Neonatal symptoms following maternal paroxetine treatment: serotonin toxicity or paroxetine discontinuation syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

7 January 2021

Neonatal drug withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

Heroin epidemics revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

Treatment of neonatal abstinence syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

Neonatal abstinence syndrome after methadone or buprenorphine exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

Methadone and buprenorphine for the management of opioid dependence in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

Slow-release morphine was not more effective than methadone in reducing neonatal abstinence syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

A proposed narcotic withdrawal score for use with newborn infants. A pragmatic evaluation of its efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

Validation of the Finnegan neonatal abstinence syndrome tool-short form.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

Recent trends in treatment admissions for prescription opioid abuse during pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

The effects of benzodiazepine use during pregnancy and lactation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

Management of neonatal abstinence syndrome: a national survey and review of practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

The impact of antenatal cocaine use on maternal characteristics and neonatal outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

A study of factors that influence the severity of neonatal narcotic withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

Congenital morphinism; a rare cause of convulsions in the newborn

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

Withdrawal symptoms in infants with the fetal alcohol syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

Withdrawal symptoms in neonates from intrauterine exposure to diazepam.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

CONGENITAL NEONATAL NARCOTICS ADDICTION: A NATURAL HISTORY.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

The Opioid dependent mother and newborn dyad: non-pharmacologic care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

Estimating coefficients in linear models: It don't make no nevermind.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

The neonatal withdrawal inventory: a simplified score of newborn withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

Finnegan neonatal abstinence scoring system: normal values for first 3 days and weeks 5-6 in non-addicted infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

Neonatal abstinence scores in opioid-exposed and nonexposed neonates: a blinded comparison

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.07.017

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YPMED.2015.07.017

1 reference

8 September 2017

1 reference

PubMed ID

26232620